Comparative Efficacy of Donor Lymphocyte Infusions in Augmenting Graft-versus-Leukemia Effect after Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Myeloid Malignancies
Acta Haematologica · 08.06.2026 · 1-9
DOI: 10.1159/000552196 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Haematologica, online erschienen am 08.06.2026. Verfasst von Maymona Abdelmagid und 20 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology, Mayo Clinic Minnesota, Rochester, Minnesota, USA. Die Arbeit nennt 18 Literaturangaben.
Abstract (Originalsprache)
Introduction
The efficacy of donor lymphocyte infusions (DLIs) among various myeloid malignancies (particularly genetic subtypes) and the optimal timing of DLI initiation remains unclear.
Methods
This was a retrospective study of 62 patients with myeloid malignancies treated with alloHSCT and DLI from years 2001 to 2022. DLI indications were therapeutic 55 (89%), preemptive 6 (10%), and prophylactic in 1 (2%) patients with complete remission (CR/CRi) in 20 patients; diagnoses included 9 (45%) acute myeloid leukemia, 6 (30%) myelodysplastic syndromes, and 3 (15%) chronic myelomonocytic leukemia among others.
Results
Among patients who received therapeutic DLI (n = 55), the best response was CR/CRi in 16 (29%) patients. At a median follow-up from the date of DLI of 75 (95% CI 35–121) months, there were 49 (79%) deaths with a median OS of 6 (95% CI 4–14) months, higher in patients in CR/CRi versus no CR/CRi (median 51 versus 4 months, p = 0.008). Presence of cytogenetic abnormalities such as complex karyotype, deletions in chromosome 5, 7, and 17p, and mutations in TP53, KRAS, NRAS, RUNX1, or JAK2 were associated with adverse outcomes.
Conclusion
DLI is an effective treatment strategy for post-transplant relapse across myeloid malignancies, with specific genetic subtypes showing poorer outcomes and survival.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Hematology, Mayo Clinic Minnesota, Rochester, Minnesota, USA.
- Department of Internal Medicine, Mayo Clinic Minnesota, Rochester, Minnesota, USA.
- Division of Hematology/Oncology, Mayo Clinic Florida, Jacksonville, Florida, USA.
- Human Cellular Therapy Lab, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
- Division of Hematology, Mayo Clinic Minnesota, Rochester, Minnesota, USA, mangaonkar.abhishek@mayo.edu.
Zitieren
APA
Abdelmagid, M., Hashi, N. J., Hefazi, M., Matin, A., Gauto Mariotti, E., Hogan, W. J., Litzow, M. R., Alkhateeb, H. B., Shah, M. V., Durani, U., Kenderian, S. S., Foran, J. M., Murthy, H. S., Kharfan-Dabaja, M. A., Roy, V., Ayala, E., Patnaik, M. M., Dingli, D., DiGuardo, M. A., …, & Mangaonkar, A. A. (2026). Comparative Efficacy of Donor Lymphocyte Infusions in Augmenting Graft-versus-Leukemia Effect after Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Myeloid Malignancies. Acta Haematologica, 1-9. https://doi.org/10.1159/000552196
Vancouver
Abdelmagid M, Hashi NJ, Hefazi M, Matin A, Gauto Mariotti E, Hogan WJ, et al. Comparative Efficacy of Donor Lymphocyte Infusions in Augmenting Graft-versus-Leukemia Effect after Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Myeloid Malignancies. Acta Haematologica. 2026:1-9. doi:10.1159/000552196
BibTeX
@article{Abdelmagid2026,
author = {Abdelmagid, Maymona and Hashi, Naima J and Hefazi, Mehrdad and Matin, Aasiya and Gauto Mariotti, Estefania and Hogan, William J and Litzow, Mark R and Alkhateeb, Hassan B and Shah, Mithun V and Durani, Urshila and Kenderian, Saad S and Foran, James M and Murthy, Hemant S and Kharfan-Dabaja, Mohamed A and Roy, Vivek and Ayala, Ernesto and Patnaik, Mrinal M and Dingli, David and DiGuardo, Margaret A and Jacob, Eapen K and Mangaonkar, Abhishek A},
title = {Comparative Efficacy of Donor Lymphocyte Infusions in Augmenting Graft-versus-Leukemia Effect after Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Myeloid Malignancies},
journal = {Acta Haematologica},
year = {2026},
pages = {1--9},
doi = {10.1159/000552196}
}
EUVIMED